Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia

Cognitive impairments associated with schizophrenia (CIAS) represent a central element of the symptomatology of this severe mental disorder. CIAS substantially determine the disease prognosis and hardly, if at all, respond to treatment with currently available antipsychotics. Remarkably, all drugs p...

Descripción completa

Detalles Bibliográficos
Autores principales: Veselinović, Tanja, Neuner, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345797/
https://www.ncbi.nlm.nih.gov/pubmed/35831706
http://dx.doi.org/10.1007/s40263-022-00935-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345797/
https://www.ncbi.nlm.nih.gov/pubmed/35831706
http://dx.doi.org/10.1007/s40263-022-00935-z

Ejemplares similares